Aethlon Medical Discloses Corporate Video Presentation
http://www.wsw.com/webcast/brileyco14/aemd.ob/. If you have not previously registered, you will be prompted to complete a brief registration form.
The corporate presentation was recorded during the B. Riley 11th Annual Investor Conference held on May 26, 2010.
About Aethlon Medical
Aethlon Medical, Inc. creates diagnostic and therapeutic device solutions for infectious disease and cancer. Our lead product, the Hemopurifier® is the first-in-class medical device to selectively capture circulating viruses and immunosuppressive proteins prior to cell and organ infection. Human studies have documented the ability of our Hemopurifier® to reduce viral load in patients infected with Hepatitis-C virus (HCV) and the Human Immunodeficiency Virus (HIV). Our primary clinical and commercialization focus is to establish the Hemopurifier® as an adjunct therapy to enhance and prolong the benefit of traditional infectious disease drug regimens.
Additional information regarding Aethlon Medical can be accessed online at www.aethlonmedical.com.
Contacts: | |
Jim Joyce | |
Chairman, CEO | |
858.459.7800 x301 | |
John P. Salvador | |
Director, Communications and Investor Relations | |
858.459.7800 x307 | |
(Logo: http://www.newscom.com/cgi-bin/prnh/20090325/LA88762LOGO-b)
SOURCE Aethlon Medical, Inc.